文献速递泌尿生殖介入腹部CT

外冷却多针可展开电极射频消融治疗T1a期肾癌

Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
PubMed 文献 · Radiol Med · 2020-03-21

回顾性评估盐水外冷却多针可展开电极经皮射频消融治疗T1a期肾细胞癌的中期结局,纳入35例患者39个病灶共41次CT引导操作(2011-2017年),初次有效率86%,无复发,3例轻度(8%)和1例重度(2.7%)围手术期并发症,91.4%患者生存,中位总生存65个月。

要点

  • 消融后以影像无对比增强判定完全肿瘤坏死,初次有效率为86%。
  • 围手术期轻度并发症3例(8%),重度并发症1例(2.7%)。
  • 血清肌酐术前1.08 mg/dl vs 术后1.11 mg/dl,差异无统计学意义(p=0.4117)。

核心结论

  • 中期结果显示,CT引导下盐水外冷却多针可展开电极射频消融治疗T1aN0M0期肾细胞癌有效且安全。
  • 本研究数据与文献中采用其他器械治疗患者的数据一致。

研究设计与样本

  • 回顾性研究,纳入35例患者共39个肾细胞癌病灶,行41次CT引导射频消融(2011-2017年)。
  • 所有患者消融前分期为T1a、N0、M0,平均肿瘤大小24.48 mm。
  • 使用4针可展开射频电极,以泵循环盐水冷却。
  • 疗效评估为操作结束时及后续随访影像上无对比增强以证实完全肿瘤坏死,随访观察期5年。

诊断标准与关键数值

  • 完全肿瘤坏死判定标准为影像上无对比增强。
  • 初次有效率86%(30/35例仅接受1次治疗)。
  • 4/35例因残留病灶接受2次治疗,1/35例接受3次治疗。

临床应用与阅片要点

  • 消融后及随访中以影像无对比增强作为完全肿瘤坏死的判定依据。
  • 术后疼痛采用NRS评估,中位值0.8。
  • 住院天数中位值2.8±1.9天。

局限性

  • 原文为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: To retrospectively evaluate the mid-term outcomes of percutaneous radiofrequency ablation (RFA) with multitined expandable electrodes externally cooled with saline solution in patients with T1a renal cell carcinoma (RCC).

MATERIALS AND METHODS: In this retrospective study, we evaluated 39 RCC in 35 patients treated with CT-guided RFA in 41 procedures (2011-2017). All patients were staged T1a, N0, M0 prior to RFA. Mean tumor size was 24.48 mm. A 4-tined expandable RFA electrode cooled with pump-circulating saline was used. Efficacy was evaluated verifying complete tumor necrosis (no contrast enhancement on imaging) at the end of the procedure and on subsequent controls. Follow-up observation period was 5 years. Minor/major complications, hospitalization days, serum creatinine and GFR pre- and post-RFA (compared using paired t test) and post-operative pain (evaluated with NRS after treatment) were considered as safety indicators. Overall survival was also calculated (Kaplan-Meier method).

RESULTS: Of 35 patients, 30/35 had 1 treatment (primary effectiveness rate 86%), 4/35 had 2 treatments and 1/35 had 3 treatments for residual disease. There were no relapses and no mid-long-term complications; 3 minor (8%) and 1 major (2.7%) complications during perioperative period were reported. Mean before and after RFA serum creatinine rates were, respectively, 1.08 mg/dl and 1.11 mg/dl (p value: 0.4117). NRS median value is 0.8. Hospitalization days median value is [2.8 ± 1.9] days. 91.4% of all patients survived, with a median overall survival time of 65 months.

CONCLUSIONS: Mid-term results show that CT-guided RFA with multitined expandable electrodes externally cooled with saline solution is an effective and safe treatment in patients with RCC-staged T1aN0M0. Data reported in our study are in line with data reported in the literature from patients treated with other devices.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. De Filippo M, Ziglioli F, Russo U, et al. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes. Radiol Med. 2020. PMID: 32206984. doi:10.1007/s11547-020-01175-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。